US FDA approves Regeneron’s 8-mg dose of eye disease drug Eylea By Reuters

© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo

(Reuters) – The U.S. Food and Drug Administration approved the 8-mg dose of Regeneron (NASDAQ:) Pharmaceuticals’ eye disease drug Eylea, the company said in a statement on Friday.


News5h: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button